Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.6602
+0.0089 (1.37%)
At close: Jun 27, 2025, 4:00 PM
0.6457
-0.0145 (-2.20%)
After-hours: Jun 27, 2025, 7:23 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $59.22 million as of June 27, 2025. Its market cap has decreased by -61.29% in one year.
Market Cap
59.22M
Enterprise Value
-29.94M
1-Year Change
-61.29%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $59.22M, an increase of 16.06%. That is a compound annual growth rate of 4.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 50.57M | -46.31% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.70B |
| Johnson & Johnson | 367.00B |
| AbbVie | 330.85B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 275.38B |
| Abbott Laboratories | 233.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |